BioCardia - Warrants (26/07/2022)'s receivables is $20K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
BioCardia - Warrants (26/07/2022) (BCDAW) currently reports a receivables of $20K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore BioCardia - Warrants (26/07/2022)'s receivables history and peer comparisons.
BioCardia - Warrants (26/07/2022)'s receivables changed from $0 to $20K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
BioCardia - Warrants (26/07/2022) reported $20K in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $20K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioCardia - Warrants (26/07/2022), and consider following BCDAW for alerts when major investors trade the stock.
BioCardia - Warrants (26/07/2022) is classified in the Healthcare sector. On receivables, it currently shows $20K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BCDAW with unrelated industries.